Sensorineural Hearing Loss, Bilateral Clinical Trials

9 recruiting

Frequently Asked Questions

Common questions about Sensorineural Hearing Loss, Bilateral clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting

Otoferlin Gene-mediated Hearing Loss Natural History Study

Sensorineural Hearing Loss, Bilateral
Akouos, Inc.150 enrolled10 locationsNCT05572073
Recruiting
Phase 1Phase 2

Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss

Sensorineural Hearing Loss, Bilateral
Akouos, Inc.22 enrolled9 locationsNCT05821959
Recruiting
Not Applicable

Comparison in New Cochlear Implanted Subjects of a Tonotopy-based Bimodal Fitting and a Conventional Fitting

Bilateral Hearing LossSensorineural Hearing Loss, Bilateral
MED-EL Elektromedizinische Geräte GesmbH20 enrolled1 locationNCT05955469
Recruiting
Not Applicable

Comparison in New Cochlear Implanted Subjects of a Tonotopy-based Bimodal Fitting With or Without Synchronization

Sensorineural Hearing Loss, Bilateral
MED-EL Elektromedizinische Geräte GesmbH20 enrolled1 locationNCT05898659
Recruiting
Not Applicable

Auditory Performances With Different Stimulation Depths in Cochlear Implanted Subjects Using a Fine Structure Strategy

Sensorineural Hearing Loss, Bilateral
MED-EL Elektromedizinische Geräte GesmbH32 enrolled1 locationNCT04591093
Recruiting

Cross-sectional and Prospective Study to Characterize Early-onset Presbycusis

Sensorineural Hearing Loss, Bilateral
Sensorion100 enrolled2 locationsNCT06354010
Recruiting
Not Applicable

Speech Perception of a Tonotopy-based Fitting for Cochlear Implant Recipients for 6 Months With Conventional Setting

Sensorineural Hearing Loss, Bilateral
MED-EL Elektromedizinische Geräte GesmbH25 enrolled1 locationNCT06723262
Recruiting
Not Applicable

Comparison of Speech Understanding Between Tonotopy-based Fitting and Setting Based on Evolutionary Algorithms

Sensorineural Hearing Loss, Bilateral
MED-EL Elektromedizinische Geräte GesmbH22 enrolled1 locationNCT06737185
Recruiting

Natural History in Children Up to 16 Years with Mild to Profound Hearing Loss Due to Mutations in GJB2 / OTOF Genes

OTOF Gene MutationDFNB9Congenital Deafness+4 more
Sensorion180 enrolled1 locationNCT05402813